Skip to content

Air Products and Chemicals APD Restructuring, Settlement and Impairment Provisions

Restructuring, Settlement and Impairment Provisions at other companies

LEC
Lincoln Electric HoldingsLECO
$2.16M-44.0%

Other financials

Income statement

See full
Revenue$3.2B+8.8%
Gross profit$987.4M+14.5%
Operating income$752.7M+132%
Net income$710.4M+141%
EPS (diluted)$3.19+141%

Balance sheet

See full
Cash & equivalents$951.0M-36.2%
Total debt$914.5M-35.2%
Total equity$15.6B+6.4%
Total assets$41.6B+7.1%

Cash flow

See full
Operating cash flow$1.1B+236%
CapEx$1.1B-41.4%
Free cash flow-$3.9M+99.8%

Valuation

See full
Market cap$62.4B-1.4%
Enterprise value$62.36B-1.4%
P/E29.7×-11.6×
P/S-0.3×

Profitability

See full
Gross margin32%0.0pp
Operating margin18.3%+6.0pp
Net margin16.9%+4.1pp

Returns & leverage

See full
Return on equity13.9%+3.5pp
Debt / equity0.1×0.0×
Current ratio1.4×+0.4×

Where this comes from

Reported directly by Air Products and Chemicals in its filing.

Tagged under the XBRL concept us-gaap:RestructuringSettlementAndImpairmentProvisions.

The official record: Air Products and Chemicals’s 10-K, filed November 20, 2025, on SEC EDGAR. View the filing →

Ask your AI about Air Products and Chemicals's restructuring, settlement and impairment provisions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Air Products and Chemicals's restructuring, settlement and impairment provisions?
Air Products and Chemicals (APD) reported restructuring, settlement and impairment provisions of $938.45M in Q3 2025.
How has Air Products and Chemicals's restructuring, settlement and impairment provisions changed year-over-year?
Air Products and Chemicals's restructuring, settlement and impairment provisions increased by 6485.6% year-over-year, from $14.25M to $938.45M.
What is the long-term trend for Air Products and Chemicals's restructuring, settlement and impairment provisions?
Over 2 years (2023 to 2025), Air Products and Chemicals's restructuring, settlement and impairment provisions has grown at a 291.7% compound annual growth rate (CAGR), from $244.6M to $3.75B.